REACTIVO DEINMUNOFLUORESCENCIA DIRECTAPARA LA IDENTIFICACIÓN YENUMERACIÓN DE CÉLULAS QUEEXPRESAN
Mexico·Clase I·III. DIAGNOSTIC AGENTS·DICIPA, S.A. DE C.V.·Registered November 11, 2021EL CYCD79A-PE (CLON: HM57) ES UNANTICUERPO MONOCLONAL (ACMO)CONJUGADO CON R- FICOERITRINA (PE)DISEÑADO PARA SU UTILIZACIÓN PORCITOMETRÍADEFLUJO(CF)COMOREACTIVODEINMUNOFLUORESCENCIADIRECTAENLAIDENTIFICACIÓN Y ENUMERACIÓN DECÉLULAS QUE EXPRESAN EL ANTÍGENOCD79Α. AGENTEDEDIAGNÓSTICOPARAUSO IN VITRO. PARA USO EXCLUSIVO ENLABORATORIOS CLÍNICOS O DE GABINETES
CYCD79A-PE (CLONE: HM57) IS A R-PHYCOERYTHRIN-CONJUGATED MONOCLONAL ANTIBODY (CCA) DESIGNED FOR USE BY FLOW CYTOMETRY (CF) AS A DIRECT IMMUNOFLUORESCENCE REAGENT IN THE IDENTIFICATION AND ENUMERATION OF CELLS EXPRESSING ANTIGEN CD79A. DIAGNOSTIC AGENT FOR IN VITRO USE. FOR USE IN CLINICAL LABORATORIES OR CABINETS ONLY
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- CYCD79A-PE
- Trade Name (English)
- CYCD79A-PE
- Analysis ID
- 1830R2021 SSA
- Registration Date
- November 11, 2021
- Name (Spanish)
- DICIPA, S.A. DE C.V.
- Name (English)
- DICIPA, S.A. DE C.V.
Access comprehensive regulatory information for REACTIVO DEINMUNOFLUORESCENCIA DIRECTAPARA LA IDENTIFICACIÓN YENUMERACIÓN DE CÉLULAS QUEEXPRESAN (DIRECT IMMUNOFLUORESCENCE REAGENT FOR THE IDENTIFICATION AND ENUMERATION OF CELLS EXPRESSING) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1830R2021 SSA and manufactured by DICIPA, S.A. DE C.V.. The device was registered on November 11, 2021.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.